Immunocellular Therapeutics Stock Cash Flow From Operations
ImmunoCellular Therapeutics fundamentals help investors to digest information that contributes to ImmunoCellular Therapeutics' financial success or failures. It also enables traders to predict the movement of ImmunoCellular Pink Sheet. The fundamental analysis module provides a way to measure ImmunoCellular Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ImmunoCellular Therapeutics pink sheet.
ImmunoCellular |
ImmunoCellular Therapeutics Company Cash Flow From Operations Analysis
ImmunoCellular Therapeutics' Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Current ImmunoCellular Therapeutics Cash Flow From Operations | (2.31 M) |
Most of ImmunoCellular Therapeutics' fundamental indicators, such as Cash Flow From Operations, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ImmunoCellular Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.
CompetitionIn accordance with the recently published financial statements, ImmunoCellular Therapeutics has (2.31 Million) in Cash Flow From Operations. This is 100.44% lower than that of the Biotechnology sector and 103.69% lower than that of the Health Care industry. The cash flow from operations for all United States stocks is 100.24% higher than that of the company.
ImmunoCellular Cash Flow From Operations Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ImmunoCellular Therapeutics' direct or indirect competition against its Cash Flow From Operations to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of ImmunoCellular Therapeutics could also be used in its relative valuation, which is a method of valuing ImmunoCellular Therapeutics by comparing valuation metrics of similar companies.ImmunoCellular Therapeutics is currently under evaluation in cash flow from operations category among its peers.
ImmunoCellular Fundamentals
Return On Equity | -23.12 | ||||
Return On Asset | -4.4 | ||||
Current Valuation | (1.69 M) | ||||
Shares Outstanding | 4.19 M | ||||
Shares Owned By Insiders | 94.96 % | ||||
Number Of Shares Shorted | 165.95 K | ||||
Price To Earning | 0.02 X | ||||
Price To Book | 0.35 X | ||||
EBITDA | (6.07 M) | ||||
Net Income | (5.15 M) | ||||
Cash And Equivalents | 933.15 K | ||||
Cash Per Share | 0.01 X | ||||
Total Debt | 2.78 M | ||||
Debt To Equity | 0.39 % | ||||
Current Ratio | 1.51 X | ||||
Book Value Per Share | (0.03) X | ||||
Cash Flow From Operations | (2.31 M) | ||||
Short Ratio | 4.13 X | ||||
Earnings Per Share | 28.91 X | ||||
Target Price | 5.0 | ||||
Beta | 1.03 | ||||
Market Capitalization | 2.21 M | ||||
Total Asset | 30.08 M | ||||
Retained Earnings | (74.14 M) | ||||
Working Capital | 22.29 M | ||||
Current Asset | 24.56 M | ||||
Current Liabilities | 2.27 M | ||||
Z Score | -2.8 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.ZLAB | Zai Lab | |
ASLE | AerSale Corp | |
ATS | AT S Austria |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Consideration for investing in ImmunoCellular Pink Sheet
If you are still planning to invest in ImmunoCellular Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ImmunoCellular Therapeutics' history and understand the potential risks before investing.
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Equity Valuation Check real value of public entities based on technical and fundamental data |